Your browser doesn't support javascript.
loading
Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis.
Senoo, Satoru; Miyahara, Nobuaki; Taniguchi, Akihiko; Oda, Naohiro; Itano, Junko; Higo, Hisao; Hara, Naofumi; Watanabe, Hiromi; Kano, Hirohisa; Suwaki, Toshimitsu; Fuchimoto, Yasuko; Kajimoto, Kazuhiro; Ichikawa, Hirohisa; Kudo, Kenichiro; Shibayama, Takuo; Tanimoto, Yasushi; Kuyama, Shoichi; Kanehiro, Arihiko; Maeda, Yoshinobu; Kiura, Katsuyuki.
Afiliação
  • Senoo S; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Miyahara N; Department of Medical Technology, Okayama University Graduate School of Health Sciences, Okayama, Japan.
  • Taniguchi A; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Oda N; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Itano J; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Higo H; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Hara N; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Watanabe H; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Kano H; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Suwaki T; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Fuchimoto Y; Department of Respiratory Medicine, Okayama City Hospital, Okayama, Japan.
  • Kajimoto K; Department of Respiratory Medicine, Japan Organization of Occupational Health and Safety Okayama Rosai Hospital, Okayama, Japan.
  • Ichikawa H; Department of Respiratory Medicine, Japanese Red Cross Kobe Hospital, Kobe, Japan.
  • Kudo K; Department of Respiratory Medicine, KKR Takamatsu Hospital, Takamatsu, Japan.
  • Shibayama T; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Tanimoto Y; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Kuyama S; Department of Respiratory Medicine, National Hospital Organization Minami-Okayama Medical Center, Hayashima, Japan.
  • Kanehiro A; Department of Respiratory Medicine, National Hospital Organization Iwakuni Clinical Center, Iwakuni, Japan.
  • Maeda Y; Department of Respiratory Medicine, Japan Organization of Occupational Health and Safety Okayama Rosai Hospital, Okayama, Japan.
  • Kiura K; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
PLoS One ; 15(8): e0236935, 2020.
Article em En | MEDLINE | ID: mdl-32853277
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Segurança / Fibrose Pulmonar Idiopática / Indóis Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Segurança / Fibrose Pulmonar Idiopática / Indóis Idioma: En Ano de publicação: 2020 Tipo de documento: Article